A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo (original) (raw)
Bhattacharya S, Ray RM, Johnson LR . (2005). STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells. Biochem J392: 335–344. ArticleCASPubMedPubMed Central Google Scholar
Bogler O, Weller M . (2002). Apoptosis in gliomas, and its role in their current and future treatment. Front Biosci7: e339–e353. CASPubMed Google Scholar
Bowman T, Garcia R, Turkson J, Jove R . (2000). STATs in oncogenesis. Oncogene19: 2474–2488. ArticleCASPubMed Google Scholar
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C et al. (1999). Stat3 as an oncogene. Cell98: 295–303. ArticleCASPubMed Google Scholar
Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R et al. (2001). Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest107: 351–362. ArticleCASPubMedPubMed Central Google Scholar
Fesik SW . (2005). Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer5: 876–885. ArticleCASPubMed Google Scholar
Ito H, Kanzawa T, Miyoshi T, Hirohata S, Kyo S, Iwamaru A et al. (2005). Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status. Hum Gene Ther16: 685–698. ArticleCASPubMed Google Scholar
Kanzawa T, Iwado E, Aoki H, Iwamaru A, Hollingsworth EF, Sawaya R et al. (2006). Ionizing radiation induces apoptosis and inhibits neuronal differentiation in rat neural stem cells via the c-Jun NH(2)-terminal kinase (JNK) pathway. Oncogene25: 3638–3648. ArticleCASPubMed Google Scholar
Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y, Kondo S . (2005). Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene24: 980–991. ArticleCASPubMed Google Scholar
Kapoor GS, O'Rourke DM . (2003). Mitogenic signaling cascades in glial tumors. Neurosurgery52: 1425–1434. ArticlePubMed Google Scholar
Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K et al. (1999). STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med189: 63–73. ArticleCASPubMedPubMed Central Google Scholar
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC et al. (2002). The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol61: 215–225; discussion 226–219. ArticlePubMed Google Scholar
Kondo Y, Hollingsworth EF, Kondo S . (2004). Molecular targeting for malignant gliomas (Review). Int J Oncol24: 1101–1109. CASPubMed Google Scholar
Konnikova L, Simeone MC, Kruger MM, Kotecki M, Cochran BH . (2005). Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells. Cancer Res65: 6516–6520. ArticleCASPubMed Google Scholar
Levy DE, Darnell Jr JE . (2002). Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol3: 651–662. ArticleCASPubMed Google Scholar
Lichtor T, Libermann TA . (1994). Coexpression of interleukin-1 beta and interleukin-6 in human brain tumors. Neurosurgery34: 669–672. CASPubMed Google Scholar
Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z et al. (1996). Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature379: 645–648. ArticleCASPubMed Google Scholar
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al. (2005). Genes that mediate breast cancer metastasis to lung. Nature436: 518–524. ArticleCASPubMedPubMed Central Google Scholar
Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J et al. (2002). Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene21: 2000–2008. ArticleCASPubMed Google Scholar
Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL et al. (2004). Genetic pathways to glioblastoma: a population-based study. Cancer Res64: 6892–6899. ArticleCASPubMed Google Scholar
Rahaman SO, Harbor PC, Chernova O, Barnett GH, Vogelbaum MA, Haque SJ . (2002). Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene21: 8404–8413. ArticleCASPubMed Google Scholar
Reardon DA, Rich JN, Friedman HS, Bigner DD . (2006). Recent advances in the treatment of malignant astrocytoma. J Clin Oncol24: 1253–1265. ArticleCASPubMed Google Scholar
Riedl SJ, Shi Y . (2004). Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol5: 897–907. ArticleCASPubMed Google Scholar
Schaefer LK, Ren Z, Fuller GN, Schaefer TS . (2002). Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene21: 2058–2065. ArticleCASPubMed Google Scholar
Song H, Wang R, Wang S, Lin J . (2005). A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc Natl Acad Sci USA102: 4700–4705. ArticleCASPubMedPubMed Central Google Scholar
Sonoda Y, Ozawa T, Hirose Y, Aldape KD, McMahon M, Berger MS et al. (2001). Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res61: 4956–4960. CASPubMed Google Scholar
Sun J, Blaskovich MA, Jove R, Livingston SK, Coppola D, Sebti SM . (2005). Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene24: 3236–3245. ArticleCASPubMed Google Scholar
Turkson J, Zhang S, Palmer J, Kay H, Stanko J, Mora LB et al. (2004). Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity. Mol Cancer Ther3: 1533–1542. CASPubMed Google Scholar
Van Meir E, Sawamura Y, Diserens AC, Hamou MF, de Tribolet N . (1990). Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res50: 6683–6688. CASPubMed Google Scholar
Wang P, Valentijn AJ, Gilmore AP, Streuli CH . (2003). Early events in the anoikis program occur in the absence of caspase activation. J Biol Chem278: 19917–19925. ArticleCASPubMed Google Scholar
Weissenberger J, Loeffler S, Kappeler A, Kopf M, Lukes A, Afanasieva TA et al. (2004). IL-6 is required for glioma development in a mouse model. Oncogene23: 3308–3316. ArticleCASPubMed Google Scholar
Yau CY, Wheeler JJ, Sutton KL, Hedley DW . (2005). Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts. Cancer Res65: 1497–1504. ArticleCASPubMed Google Scholar